UTHR FY 2012 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$916M+23.3% YoY

Gross Profit

$797M87.0% margin

Operating Income

$422M46.0% margin

Net Income

$304M33.2% margin

EPS (Diluted)

$5.71

Cash Flow

Operating Cash Flow

$324M

Free Cash Flow

$212M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$532M

Stockholders' Equity

$1.1B

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$916M	$743M	+23.3%
Gross Profit	$797M	$654M	+21.8%
Operating Income	$422M	$318M	+32.7%
Net Income	$304M	$218M	+39.7%